Neurodevelopmental support

"Neurodevelopmental support" is **not the name of a specific molecule, receptor, enzyme, transporter, or other canonical therapeutic target**. Instead, it refers broadly to strategies—often clinical or educational—that aim to promote healthy brain development and function in children and adults with neurodevelopmental disorders such as autism spectrum disorder (ASD), Rett syndrome, fragile X syndrome (FXS), and schizophrenia[2][4][5]. The term encompasses diverse approaches including behavioral therapies, pharmacological interventions targeting various pathways implicated in these conditions (such as synaptic proteins like neuroligins and neurexins[2], transcription factors like MeCP2[1][4], growth factors like IGF1[4]), and supportive care. Because "neurodevelopmental support" does not correspond to any single gene product or druggable protein family—and instead describes an area of clinical practice—it cannot be classified within standard molecular target frameworks used for drug discovery. Therefore, it should not be treated as a canonical therapeutic target for structured data purposes.

Other names

Neurodevelopmental support is not a recognized molecular target; it is a broad, non-specific term referring to processes or interventions that aid neurodevelopment.